AlloSource enrolled the first patient in a study to evaluate the effectiveness of ProChondrix CR® fresh cryopreserved osteochondral allograft, when used on cartilage defects in the knee.
Brainlab has acquired Medineering, a developer of application-specific robotic technologies. The move supports Brainlab's growing market reach into ambulatory surgery centers.
RTI Surgical enrolled the first patient in FORTE, a clinical evaluation of the Fortilink® interbody fusion device in the treatment of degenerative disc disease. Enrollment is slated for completion in 1Q20.
As was shown last week at AAOS, companies are taking strides to connect their devices with technologies that support improved patient outcomes. That connection can come in the form of M&A activity - which certainly applies to transactions announced over the month of March in joint replacement.
Smith & Nephew's POLAR3 total hip system demonstrated excellent survivorship and significantly higher patient satisfaction vs. other cementless stems in National Joint Registry in the U.K.